Chaires GR, Palacios CA, Monares ZE, Poblano MM, Aguirre SJ, Franco GJ

Language: Spanish
References: 7
Page: 226-229
PDF size: 81.48 Kb.

ABSTRACT

Objective: To determine the effectiveness of a set of measures for the prevention of ventilator-associated pneumonia (VAP).
Design and site: A retrospective study conducted in the Department of Critical Care Medicine «Dr. Mario Shapiro» ABC Medical Center, from January 1/2010 to May 31/2012.
Patients: Over 18 years, mechanical ventilation for more than 48 hours, informed consent.
Interventions: Diagnosis based on the isolation of pathogens compatible with VAP and reviewed by the Committee on Infections and Critical Care Medicine Department. It was established the following preventive measures: avoid ventilator circuit changes, hand hygiene, oral chlorhexidine, daily suspension of sedation, staff education, adequate cuff pressure of the endotracheal tube, aspiration of subglottic secretions; sucralfate for gastric ulcer prophylaxis; semifowler position.
Results: We quantified 4,074 ventilator days. After application of the measures, the rate of VAP showed a progressive decline. We found a statistically significant difference between the mean rate of the years 2010 and 2011 compared with the 2012 (p = 0.003 and p = 0.001, respectively).
Conclusions: A group of preventive measures succeeded in reducing the incidence of VAP.

REFERENCES

1. Niederman MS, Craven DE, Bonten MJ, et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.

2. Klompas M, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007;147:803-5.

3. Lisboa T, Díaz E, Sa-Borges M, et al. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 2008;134:1208-16.

4. Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 2011;17:464-71.

5. Kollef MH. Prevention of ventilator-associated pneumonia or ventilator-associated complications: a worthy, yet challenging, goal. Crit Care Med 2012;40(1):271-7.

6. Rello J, Lode H, Cornaglia G, et al. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010;36(5):773-80.

7. Klompas M. Ventilator-associated pneumonia: Is zero possible? Clin Infect Dis 2010;51:1123-6.